Ayurvedic treatment of near nearsightedness (a refractive error)

An Open Labelled Comparative Clinical Study To Evaluate The Effect Of Go-Ghrita Tarpana And Triphala Ghrita Tarpana On Antero-Posterior Diameter In Axial-Myopia

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021269

Enrollment

Registered

2019-09-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

Intervention1: Go-Ghrita: Go Ghrita Is Used For Akshi Tarpana route of administration - externally over eye Dose- 15 ml Frequency - daily once for 7 days Control Intervention1: Triphala ghrita: Tri

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having signs and symptoms of axial myopia 2.Patients between the age group of 7 to 20 years 3.Patients with refractive error up to 5 Diopter

Exclusion criteria

Exclusion criteria: 1.Other forms of Refractive errors and their complications. 2.Patients having other ocular disease. 3.Those who are contraindicated for Tarpana.

Design outcomes

Primary

Measure	Time frame
Decrease in A-P diameter of eyeball & Improvement of visionTimepoint: Improvement in the vision along with the decrease in A-P diameter after 7 days of akshi tarpana and 60 days of follow up	—

Secondary

Measure	Time frame
Improvement of vision along with reduction of asthenopic symptoms and decrease in Ap diameter of eye ball.Timepoint: after 60 days	—

Countries

India

Contacts

Public ContactDr Veerayya R Hiremath

SJG Ayrvedic Medical College.

drvrh.aug15@gmail.com9448544376

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026